Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7952 results

Sort By:

TOP 2301: Neoadjuvant Chemo for NSCLC

Study ID: NCT06385262
Start Date: 2025-03-17
End Date: 2029-10-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

126

Intervention / Treatment

Alrogakebab

Cemiplimab

Chemotherapy

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Study ID: NCT06445062
Start Date: 2024-05-24
End Date: 2027-07-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

1130

Intervention / Treatment

RMC-6236

mFOLFOX6 regimen

Infatuating

mFOLFIRINOX regimen

cetuximab

Gemcitabine

nab-paclitaxel

RMC-9805

Sponsor

Revolution Medicines, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Customized 3D Printed Oral Stents During Head and Neck Radiotherapy

Study ID: NCT04870762
Start Date: 2021-05-26
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

119

Intervention / Treatment

Best Practice

Medical Device Usage and Evaluation

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

Study ID: NCT05423691
Start Date: 2022-12-27
End Date: 2026-12-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

24

Intervention / Treatment

CK0804

Sponsor

Cellenkos, Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma

Study ID: NCT06594991
Start Date: 2024-09-10
End Date: 2027-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

88

Intervention / Treatment

Familimab

Cemiplimab

Ipilimumab

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Study with L19TNF in Combination with Lomustine in Patients with Glioblastoma At Progression or Recurrence

Study ID: NCT06336291
Start Date: 2024-05-22
End Date: 2026-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

90

Intervention / Treatment

L19TNF

L19TNF

L19TNF

Lomustine

Lomustine

Sponsor

Philogen S.p.A.

Source: clinicaltrials.gov

Share:
Add to list

RADVAX™ for Relapsed/Refractory Non-Hodgkin Lymphoma: A Phase II Trial of Pembrolizumab + Low Dose Radiotherapy

Study ID: NCT04827862
Start Date: 2022-07-01
End Date: 2025-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Pembrolizumab

Sponsor

Abramson Cancer Center at Penn Medicine

Source: clinicaltrials.gov

Share:
Add to list

Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia

Study ID: NCT06333262
Start Date: 2024-04-22
End Date: 2029-02-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Pester

Obinutuzumab

Sponsor

Inhye Ahn

Source: clinicaltrials.gov

Share:
Add to list

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

Study ID: NCT02958462
Start Date: 2017-01-16
End Date: 2035-09-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

2000

Intervention / Treatment

Biospecimen Collection

Bone Marrow Biopsy

Punch Biopsy

Buccal Swab

Clinical Evaluation

Genetic Counseling

Quality-of-Life Assessment

Electronic Health Record Review

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

Study ID: NCT04452591
Start Date: 2020-10-27
End Date: 2029-12-24
Study Type

Interventional

Study Phase

Phase3

No. of Participants

190

Intervention / Treatment

Cretostimogene grenadenorepvec

n-dodecyl-B-D-maltoside

Sponsor

CG Oncology, Inc.

Source: clinicaltrials.gov

Share:
Add to list